Vision test study for macular eye disorders
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older.
- You have either geographic atrophy (advanced dry age-related macular degeneration), mild to moderate diabetic retinopathy (with or without macular swelling), or you are a healthy person with no eye disease.
- Your vision (with glasses or contacts) is between roughly 20/20 and 20/200.
- You have not had an eye injection or laser in the study eye in the last 6 months.
- You do not have cataracts worse than mild, glaucoma, or a history of eye strokes.
- You can read English and are willing to come to appointments (healthy volunteers come only once).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Hear when a new Dry AMD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.